Zevia PBC (NYSE:ZVIA – Get Free Report) has been given a consensus recommendation of “Hold” by the six analysts that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and three have issued a buy recommendation on the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $4.4250.
Separately, Weiss Ratings raised Zevia PBC from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, July 17th.
Check Out Our Latest Stock Analysis on Zevia PBC
Zevia PBC Price Performance
Zevia PBC (NYSE:ZVIA – Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported ($0.03) EPS for the quarter, meeting analysts’ consensus estimates of ($0.03). Zevia PBC had a negative return on equity of 13.43% and a negative net margin of 4.11%.The business had revenue of $45.00 million for the quarter, compared to the consensus estimate of $44.21 million. As a group, equities research analysts expect that Zevia PBC will post -0.1 earnings per share for the current year.
Insiders Place Their Bets
In other news, major shareholder De Depot Et Placement D. Caisse sold 2,150,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $1.90, for a total transaction of $4,085,000.00. Following the completion of the sale, the insider owned 11,400,428 shares in the company, valued at approximately $21,660,813.20. The trade was a 15.87% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 7.70% of the company’s stock.
Institutional Investors Weigh In On Zevia PBC
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Jefferies Financial Group Inc. acquired a new position in Zevia PBC in the fourth quarter valued at $4,864,000. Vanguard Group Inc. increased its position in shares of Zevia PBC by 4.8% during the third quarter. Vanguard Group Inc. now owns 1,966,289 shares of the company’s stock worth $5,348,000 after purchasing an additional 89,810 shares in the last quarter. Kanen Wealth Management LLC acquired a new stake in shares of Zevia PBC during the first quarter worth about $1,462,000. Geode Capital Management LLC lifted its holdings in shares of Zevia PBC by 29.3% in the 4th quarter. Geode Capital Management LLC now owns 1,023,391 shares of the company’s stock valued at $2,375,000 after purchasing an additional 231,965 shares during the last quarter. Finally, Renaissance Technologies LLC lifted its holdings in shares of Zevia PBC by 33.3% in the 1st quarter. Renaissance Technologies LLC now owns 811,826 shares of the company’s stock valued at $950,000 after purchasing an additional 203,000 shares during the last quarter. 53.21% of the stock is currently owned by institutional investors and hedge funds.
Zevia PBC Company Profile
Zevia PBC, headquartered in Los Angeles, is a Public Benefit Corporation that produces zero-calorie, naturally sweetened beverages. Founded in 2007, the company went public through a merger with a special purpose acquisition company in March 2021. Zevia’s mission centers on offering healthier drink alternatives by using stevia leaf extract and other plant-based ingredients rather than sugar or artificial sweeteners.
The company’s product portfolio spans multiple categories, including carbonated sodas, sparkling water, energy drinks, mixers and flavored teas.
Further Reading
- Five stocks we like better than Zevia PBC
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for Zevia PBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zevia PBC and related companies with MarketBeat.com's FREE daily email newsletter.
